![]() Affimed N.V. Affimed is a NASDAQ-listed clinical-stage biopharmaceutical company focused on discovering and developing targeted immuno-oncology therapies. | ![]() Avid Bioservices Avid Bioservices, formerly Peregrine Pharmaceuticals, is a biopharmaceutical company. | ![]() Zogenix Specialty pharmaceutical developing CNS and pain therapies and featuring DosePro needle free delivery technology. | |
Founding Date | Founding Date 2000 | Founding Date 1981 | Founding Date 2006 |
Type | Type Public | Type Public | Type Subsidiary |
Tags | |||
Locations | Locations Heidelberg, DE HQ | Locations Tustin, US HQ | Locations Emeryville, US HQ Maidenhead, GB |
Employees | Employees 76 | Employees 21114% increase | Employees 743% increase |
Valuation ($) | Valuation ($) 52.5 m | Valuation ($) 649.4 m | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) €8.3m (FY, 2023) | Revenue (est.) $139.9m (FY, 2024) | Revenue (est.) $81.7m (FY, 2021) |
Cost of goods | Cost of goods N/A | Cost of goods $132.6m (FY, 2024) | Cost of goods $4.8m (FY, 2021) |
Gross profit | Gross profit €13m (FY, 2023) | Gross profit $7.3m (FY, 2024) | Gross profit N/A |
Net income | Net income (€105.9m) (FY, 2023) | Net income ($140.8m) (FY, 2024) | Net income ($227.4m) (FY, 2021) |

Avid Bioservices, formerly Peregrine Pharmaceuticals, is a biopharmaceutical company.
View company
Specialty pharmaceutical developing CNS and pain therapies and featuring DosePro needle free delivery technology.
View company